CDC6 and hepatocellular carcinoma: CDC6, which acts as a regulator in the early stages of DNA replication and as a checkpoint controller before mitosis, has been associated with the clinical progression of HCC and may be utilized as a biomarker in patients with this kind of cancer73,74.